Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Arild Aarli

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neurology|June 5, 2013
When is a global health program global?Johan Arild Aarli, Oded Abramsky
Archives of Neurology|March 16, 2005
Striational antibodies in myasthenia gravis: reactivity and possible clinical significanceFredrik Romi, Geir Olve Skeie, Nils Erik Gilhus, et al.
Muscle & Nerve|January 1, 2003
Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitroGeir Olve Skeie, Ase Mygland, Susan Treves, et al.
Acta Neurologica Scandinavica|January 7, 2004
Lifestyle and late effects after poliomyelitis. A risk factor study of two populationsTiina Rekand, Janika Kõrv, Elisabeth Farbu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neurology|June 5, 2013
When is a global health program global?Johan Arild Aarli, Oded Abramsky
Archives of Neurology|March 16, 2005
Striational antibodies in myasthenia gravis: reactivity and possible clinical significanceFredrik Romi, Geir Olve Skeie, Nils Erik Gilhus, et al.
Muscle & Nerve|January 1, 2003
Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitroGeir Olve Skeie, Ase Mygland, Susan Treves, et al.
Acta Neurologica Scandinavica|January 7, 2004
Lifestyle and late effects after poliomyelitis. A risk factor study of two populationsTiina Rekand, Janika Kõrv, Elisabeth Farbu, et al.
Pageof 1